Literature DB >> 7740653

Gene amplifications in advanced-stage human prostate cancer.

G Fournier1, A Latil, Y Amet, J H Abalain, A Volant, P Mangin, H H Floch, R Lidereau.   

Abstract

Gene amplification is a model of proto-oncogene alterations occasionally observed in human tumors. This amplification can, in some cases, have prognostic value (N-myc in neuroblastoma, c-erbB2 and int-2 in breast cancer, etc.). Amplifications of the proto-oncogenes c-myc, c-erbB2 and int-2 have not yet been report in prostate adenocarcinoma, which, like breast cancer, is hormone dependent. We sought amplifications of these three proto-oncogenes by means of Southern blotting in 15 human prostate adenocarcinoma specimens, most of which were advanced (7 stage C and 6 stage D1 or D2). We confirmed the lack of c-myc and c-erbB2 amplification, regardless of the stage, in contrast to the case of breast cancer. Int-2 amplification was observed in one advanced tumor with bone metastases, out of a total of six stage D tumors. The precise frequency of int-2 amplification and its role in prostate carcinogenesis remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7740653     DOI: 10.1007/BF00296872

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  30 in total

1.  Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.

Authors:  T C Thompson; J Southgate; G Kitchener; H Land
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

2.  Amplification of the int-2 gene in human head and neck squamous cell carcinomas.

Authors:  K D Somers; S L Cartwright; G L Schechter
Journal:  Oncogene       Date:  1990-06       Impact factor: 9.867

3.  Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers.

Authors:  R Buttyan; I S Sawczuk; M C Benson; J D Siegal; C A Olsson
Journal:  Prostate       Date:  1987       Impact factor: 4.104

4.  Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis.

Authors:  K Fan
Journal:  J Urol       Date:  1988-02       Impact factor: 7.450

5.  Clinical evidence for and implications of the multistep development of prostate cancer.

Authors:  H B Carter; S Piantadosi; J T Isaacs
Journal:  J Urol       Date:  1990-04       Impact factor: 7.450

6.  Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.

Authors:  C Escot; C Theillet; R Lidereau; F Spyratos; M H Champeme; J Gest; R Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

7.  Natural history of localised prostatic cancer. A population-based study in 223 untreated patients.

Authors:  J E Johansson; H O Adami; S O Andersson; R Bergström; U B Krusemo; W Kraaz
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

8.  Chromosomal localization of the human proto-oncogene c-ets.

Authors:  C de Taisne; A Gegonne; D Stehelin; A Bernheim; R Berger
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

9.  Expression of cellular oncogenes in human prostatic carcinoma cell lines.

Authors:  A W Rijnders; J A van der Korput; G J van Steenbrugge; J C Romijn; J Trapman
Journal:  Biochem Biophys Res Commun       Date:  1985-10-30       Impact factor: 3.575

10.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.

Authors:  E Schuuring; E Verhoeven; W J Mooi; R J Michalides
Journal:  Oncogene       Date:  1992-02       Impact factor: 9.867

View more
  3 in total

1.  Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.

Authors:  Kimmo J Savinainen; Outi R Saramäki; Marika J Linja; Ola Bratt; Teuvo L J Tammela; Jorma J Isola; Tapio Visakorpi
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion.

Authors:  N Morita; H Uemura; K Tsumatani; M Cho; Y Hirao; E Okajima; N Konishi; Y Hiasa
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

3.  Genetic alterations in benign prostatic hyperplasia patients.

Authors:  Hanaa Mahmoud Mohamed; Magdy Sayed Aly; Tarek Dardeer Hussein
Journal:  Ger Med Sci       Date:  2017-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.